Crohn's disease exclusion diet as an add‐on to antitumor necrosis factor‐α therapy in children with moderate‐to‐severe Crohn's disease

Paolo Lionetti has received speaker fees from Takeda, Dr. Falk, Nestlè Health Science, and Nutricia. The remaining authors declare no conflicts of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.